Fussbroich et al. (2015) investigated the immune modulatory effect of soyasaponin I on TLR2- and TLR4-induced inflammation by stimulating the human acute myeloid leukemia-derived cell line MUTZ-3 with four different types of stimulators (the gram-negative Escherichia coli, gram-positive Staphylococcus aureus, LPS or peptidoglycans PGN). Here, TLR2 is linked to acute myeloid leukemia.